Companies / Argentina
Lilly, HLB Expand Research And Production
February 2007 | FDI AlertUS drugmaker Eli Lilly and local player HLB Pharma have announced investments in research and production in Argentina, in what is still, in BMI's view, one of the most difficult local drug markets in Latin America.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
